BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 3009181)

  • 1. Purification and characterization of a novel, oligomeric, plasminogen kringle 4 binding protein from human plasma: tetranectin.
    Clemmensen I; Petersen LC; Kluft C
    Eur J Biochem; 1986 Apr; 156(2):327-33. PubMed ID: 3009181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of kringles derived from human plasminogen on fibrinolysis in vitro.
    Sugiyama N; Iwamoto M; Abiko Y
    Thromb Res; 1987 Aug; 47(4):459-68. PubMed ID: 2821651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A tetranectin-related protein is produced and deposited in extracellular matrix by human embryonal fibroblasts.
    Clemmensen I; Lund LR; Christensen L; Andreasen PA
    Eur J Biochem; 1991 Feb; 195(3):735-41. PubMed ID: 1999192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and some properties of rat alpha 2-plasmin inhibitor.
    Kumada T; Abiko Y
    Thromb Res; 1984 Oct; 36(2):143-52. PubMed ID: 6438828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and some properties of a new fast-reacting plasmin inhibitor in human plasma.
    Collen D
    Eur J Biochem; 1976 Oct; 69(1):209-16. PubMed ID: 136345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding site of alpha 2-plasmin inhibitor to plasminogen.
    Sugiyama N; Sasaki T; Iwamoto M; Abiko Y
    Biochim Biophys Acta; 1988 Jan; 952(1):1-7. PubMed ID: 3334852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and characterization of a plasminogen activator secreted by a pig kidney cell line.
    Sudol M; Reich E
    Biochem J; 1984 May; 219(3):971-8. PubMed ID: 6430276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional analogy between lipoprotein(a) and plasminogen in the binding to the kringle 4 binding protein, tetranectin.
    Kluft C; Jie AF; Los P; de Wit E; Havekes L
    Biochem Biophys Res Commun; 1989 Jun; 161(2):427-33. PubMed ID: 2525378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a recombinant chimeric plasminogen activator with enhanced fibrin binding.
    Jiao J; Yu M; Ru B
    Biochim Biophys Acta; 2001 Apr; 1546(2):399-405. PubMed ID: 11295444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of molecular forms of plasminogen and plasmin-inhibitor complexes in urokinase-activated human plasma.
    Müllertz S; Thorsen S; Sottrup-Jensen L
    Biochem J; 1984 Oct; 223(1):169-77. PubMed ID: 6208893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the activation mechanism of fibrinolytic enzyme system in plasma by human pancreatic elastase.
    Toki N; Takasugi S; Ishizu K; Sato H; Sumi H
    Thromb Haemost; 1982 Feb; 47(1):8-13. PubMed ID: 6176043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the murine plasma fibrinolytic system.
    Lijnen HR; van Hoef B; Beelen V; Collen D
    Eur J Biochem; 1994 Sep; 224(3):863-71. PubMed ID: 7523120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of tissue-type plasminogen activator-inhibitor complexes from human plasma. Evidence for a rapid plasminogen activator inhibitor.
    Thorsen S; Philips M
    Biochim Biophys Acta; 1984 Nov; 802(1):111-8. PubMed ID: 6435684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of urokinase by complex formation with human antithrombin III in absence and presence of heparin.
    Clemmensen I
    Thromb Haemost; 1978 Jun; 39(3):616-23. PubMed ID: 705690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of the modified form of human plasminogen by alpha 2-macroglobulin-plasmin complexes.
    Yamamoto J; Okamoto U; Morita S; Asada N; Yamaoka M
    Jpn J Physiol; 1985; 35(6):1013-21. PubMed ID: 2422420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and characterization of a new cytosolic glutathione S-transferase (glutathione S-transferase X) from rat liver.
    Friedberg T; Milbert U; Bentley P; Guenther TM; Oesch F
    Biochem J; 1983 Dec; 215(3):617-25. PubMed ID: 6661188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of the binding sites of porcine tissue-type plasminogen activator and plasminogen to heparin.
    Soeda S; Kakiki M; Shimeno H; Nagamatsu A
    Biochim Biophys Acta; 1987 Dec; 916(3):279-87. PubMed ID: 3120775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Affinity-chromatographic purification of human alpha 2-antiplasmin.
    Wiman B
    Biochem J; 1980 Oct; 191(1):229-32. PubMed ID: 6907016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topography of the high-affinity lysine binding site of plasminogen as defined with a specific antibody probe.
    Miles LA; Plow EF
    Biochemistry; 1986 Nov; 25(22):6926-33. PubMed ID: 3099830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transport of urokinase across the intestinal tract of normal human subjects with stimulation of synthesis and/or release of urokinase-type proteins.
    Toki N; Sumi H; Sasaki K; Boreisha I; Robbins KC
    J Clin Invest; 1985 Apr; 75(4):1212-22. PubMed ID: 3921568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.